Status:

UNKNOWN

Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers

Lead Sponsor:

Hospital Universitario Dr. Jose E. Gonzalez

Conditions:

BCG

COVID-19

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

In Mexico the total number of confirmed cases of COVID-19 is 232, 000 and 28,510 deaths. Health workers are at high risk of COVID-19 infection. Their absence from work dramatically limits the ability ...

Detailed Description

The study design is a randomized, double-blinded, placebo-controlled clinical trial. Age stratified randomization (\<45 years and\> 45 years) was performed using permuted blocks with allocation conce...

Eligibility Criteria

Inclusion

  • Health workers who are working onsite in patients' areas with COVID-19
  • Age \> 18 years
  • Negative specific IgG and IgM antibodies test result for SARS CoV-2 before the enrollment.
  • Provide a signed and dated informed consent form

Exclusion

  • Age \<18 years
  • Positive test for specific antibodies IgG and IgM antibodies result for SARS Cov-2
  • Primary or secondary immunosuppression
  • Use of immunosuppression drugs, use of hydroxychloroquine, cloroquine, Azithromycin, Lopinavir/ritonavir, Ivermectin or any other drug used to treat patients COVID-19 before the enrollment.
  • Chemotherapy treatment
  • Presence of antibodies IgA, IgM, IgG against SARS-CoV-2
  • Pregnancy or breastfeeding
  • Missing informed consent form
  • Fever \> 38° in the previous 24 hours
  • Any BCG vaccine contraindication
  • History of previous allergy to the components of the vaccine
  • Already part of any other trial
  • Previous or active tuberculosis (TB) disease
  • Another vaccine administrated 4 months before the start of the trial.
  • Any underlying history of malignancy or lymphoma.
  • Actual treatment with steroids
  • Absence of more than 1 month from the hospital, from the study period.

Key Trial Info

Start Date :

July 21 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2021

Estimated Enrollment :

908 Patients enrolled

Trial Details

Trial ID

NCT04461379

Start Date

July 21 2020

End Date

January 1 2021

Last Update

November 13 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario "José E. González"

Monterrey, Nuevo León, Mexico, 64460